Stock ALLR ALLARITY THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Allarity Therapeutics, Inc.

Equities

ALLR

US0167444019

Real-time Estimate Cboe BZX
Other stock markets
 15:52:42 21/05/2024 BST 		5-day change 1st Jan Change
0.605 USD -3.59% Intraday chart for Allarity Therapeutics, Inc. -22.66% -94.47%
05-06 Allarity Therapeutics Says Stockholders' Equity 'Significantly' Exceeds Nasdaq's $2.5 Million Minimum Rule MT
05-02 Wall Street Set to Open Higher Thursday After Fed Holds Rate Steady, Jobless Claims Lower Than Expected MT

Chart calendar Allarity Therapeutics, Inc.

1772f376e0c3edf49675f65.1hrVWEaFnV5xcUE_-Rx4eGZXoxF0LWe0QO6FjccEMuA.oCOaPhfM-QopCzlPzXkzTx5jlnc8YQnWEYHfz4hzQqWZdZkaIObxLkdJJg~0d1360679dbb4cf77061ee5577352405

Upcoming events on Allarity Therapeutics, Inc.

14/05/2024 21:01 Q1 2024 Earnings Release
07/10/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)
18/05/2025 Q4 2024 Earnings Release (Projected)
22/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Allarity Therapeutics, Inc.

01/04/2024 15:00 Extraordinary Shareholders Meeting
08/03/2024 12:15 Q4 2023 Earnings Release
28/02/2024 Biomarkers Congress
13/11/2023 Biomarkers Europe Congress
18/10/2023 ThinkEquity Conference
23/06/2023 18:00 Extraordinary Shareholders Meeting
03/06/2023 14:00 American Society of Clinical Oncology Conference - Abstract # 3130
19/03/2023 Extraordinary Shareholders Meeting
03/02/2023 18:00 Annual General Meeting
02/12/2022 18:00 Annual General Meeting
15/11/2022 21:01 Q3 2022 Earnings Release
11/10/2022 21:05 Interim 2022 Earnings Release
29/09/2022 20:00 Ladenburg Thalmann Healthcare Conference
27/05/2022 22:37 Q1 2022 Earnings Release
17/05/2022 00:40 FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,12
0,54
-78.12%		0,00
0,15
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-9,81
-17,2
42.98%		-9,31
-8,96
-3.88%		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-21,8
-17,0
-28.61%		-9,47
-9,13
-3.68%		0,00


-32,7
-31,5
-3.64%		-17,1
-16,7
-2.5%
-23,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-25,8
-17,3
-49.27%		-9,33
-7,71
-21.03%		0,00


-17,6
-20,0
12.17%		-11,8
-14,5
18.58%
-16,4

Net income
Million USD		Released
Forecast
Spread 		-20,4
-15,4
-32.08%		-7,53
-6,85
-9.81%		-26,6


-21,1
-20,4
-3.35%		-20,4
-14,5
-40.66%
-16,4

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


-61 880
-60 760
-1.84%		-205
-4 117
95.02%
-2,60

Announcement Date31/03/2031/03/2117/05/2213/03/2308/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,30
-5,35
19.51%		-4,33
-5,61
22.86%		-4,56
-3,30
-38.43%		-4,97
-4,33
-14.67%		-3,66
-3,63
-0.94%		-4,16
-3,59
-15.9%		-4,43
-3,51
-25.95%		-4,88
-4,47
-9.15%		-4,24
-4,94
14.12%
-5,92


-6,22


-6,53

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,31
-5,35
19.42%		-4,65
-5,61
17.09%		-5,03
-2,89
-74.18%		-3,14
-4,38
28.24%		-3,35
-3,63
7.53%		-2,38
-3,59
33.63%		-4,45
-3,51
-26.55%		-1,64
-4,34
62.19%		-3,85
-3,16
-21.78%
-3,10


-5,19


-5,00

Net income
Million USD		Released
Forecast
Spread 		-4,65
-5,35
12.97%		-4,66
-5,61
17.02%		-6,68
-2,89
-131.33%		-3,10
-4,38
29.13%		-3,36
-3,63
7.42%		-9,79
-3,59
-172.89%		-5,55
-3,51
-58%		-1,72
-4,34
60.28%		-3,88
-3,16
-22.82%
-3,10


-5,19


-5,00

EPS
USD		Released
Forecast
Spread 		-15 680
-18 480
15.15%		-14 560
-19 320
24.64%		-19 040
-7 140
-166.67%		-6 440
-11 760
45.24%		-3 544
-6 304
43.78%		-526
-224
-134.85%		-44,8
-163
72.58%
-5,00

-22,1
-1,76
-1157.95%
-0,29


-0,28


-0,27

Announcement Date27/05/2222/08/2214/11/2213/03/2311/05/2314/08/2314/11/2308/03/2414/05/24---

Upcoming sector events for Allarity Therapeutics, Inc.

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Allarity Therapeutics, Inc.

17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 21:01 CELCUITY INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 13:00 IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALLR Stock
  4. Calendar Allarity Therapeutics, Inc.